Omnicell Stockholders Approve 1.6 Million Share Increase for Equity Incentive Plan
OMCL sits 64% above its 52-week low of $26.845.
Summary
Omnicell stockholders approved an increase of 1.6 million shares to the company's equity incentive plan, finalizing a significant potential dilution of approximately 3.5% of outstanding shares.
Key Events · Financing and Capital Events · OMCL
-
Share Authorization Approved
Stockholders approved adding 1.6 million shares to the 2009 Equity Incentive Plan, increasing the pool of shares authorized for future equity awards. This authorization represents a potential dilution of approximately 3.5% of current outstanding shares.
-
Officer Exculpation Adopted
An amendment to the Certificate of Incorporation was approved, providing exculpation from personal liability for certain officers as permitted by Delaware law.
-
Annual Meeting Results
Stockholders elected three Class I Directors, approved named executive officer compensation on an advisory basis, and ratified Deloitte & Touche LLP as the independent registered public accounting firm for 2026.
Analysis · OMCL · Technology
Stockholders approved an amendment to the 2009 Equity Incentive Plan, authorizing an additional 1.6 million shares for issuance. If all these authorized shares were issued, dilution would be approximately 3.5% of current outstanding shares. While the proposal for this increase was previously disclosed in the DEF 14A on April 13, 2026, this approval finalizes the authorization, confirming the future potential for share dilution.
At the time of this filing, OMCL was trading at $44.10 on NASDAQ in the Technology sector, with a market capitalization of approximately $2B. The 52-week trading range was $26.85 to $55.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.